CIK 0000875045 · Large accelerated filer
BIOGEN INC.
Sign in to watch- Ticker
- BIIB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330112644
- Phone
- 6176792000
- Business address
- 225 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-02 | Singhal Priya Head of Development | Shares withheld for taxes | −543 | $268.75 | $146K | 3,257.39 |
| 2023-03-02 | Singhal Priya Head of Development | Option exercise | +297 | 3,554.39 | ||
| 2023-03-02 | Singhal Priya Head of Development | Shares withheld for taxes | −144 | $268.75 | $39K | 3,410.39 |
| 2023-03-02 | Singhal Priya Head of Development | Option exercise · Restricted Stock Unit | −297 | 341 | ||
| 2023-03-02 | Singhal Priya Head of Development | Other disposition · Restricted Stock Unit | −341 | 0 | ||
| 2023-02-17 | Singhal Priya Head of Development | Option exercise | +460 | 3,951.39 | ||
| 2023-02-17 | Singhal Priya Head of Development | Shares withheld for taxes | −151 | $278.38 | $42K | 3,800.39 |
| 2023-02-17 | Singhal Priya Head of Development | Option exercise · Restricted Stock Unit | −460 | 1,282 | ||
| 2023-02-17 | Singhal Priya Head of Development | Other disposition · Restricted Stock Unit | −408 | 874 | ||
| 2023-02-17 | Murphy Nicole Head of Pharm Ops and Tech | Option exercise | +480 | 5,579.29 | ||
| 2023-02-17 | Murphy Nicole Head of Pharm Ops and Tech | Shares withheld for taxes | −233 | $278.38 | $65K | 5,099.29 |
| 2023-02-17 | Murphy Nicole Head of Pharm Ops and Tech | Option exercise · Restricted Stock Unit | −480 | 1,334 | ||
| 2023-02-17 | Murphy Nicole Head of Pharm Ops and Tech | Other disposition · Restricted Stock Unit | −426 | 908 | ||
| 2023-02-17 | MCDONNELL MICHAEL R EVP, Chief Financial Officer | Option exercise | +2,561 | 10,147 | ||
| 2023-02-17 | MCDONNELL MICHAEL R EVP, Chief Financial Officer | Shares withheld for taxes | −1,310 | $278.38 | $365K | 7,586 |
| 2023-02-17 | MCDONNELL MICHAEL R EVP, Chief Financial Officer | Option exercise · Restricted Stock Unit | −2,561 | 7,107 | ||
| 2023-02-17 | MCDONNELL MICHAEL R EVP, Chief Financial Officer | Other disposition · Restricted Stock Unit | −2,271 | 4,836 | ||
| 2023-02-17 | Kramer Robin Chief Accounting Officer | Option exercise | +512 | 3,843.75 | ||
| 2023-02-17 | Kramer Robin Chief Accounting Officer | Shares withheld for taxes | −238 | $278.38 | $66K | 3,331.75 |
| 2023-02-17 | Kramer Robin Chief Accounting Officer | Option exercise · Restricted Stock Unit | −512 | 1,422 |
Page 22 of 29 · 579 trades